Published in Elder Law Weekly, June 22nd, 2005
The significance of this research alliance is reinforced by findings being presented at this week's meeting of the American Psychiatric Association (APA) indicating that Aspect's technology may be able to help clinicians improve patient response to antidepressant therapy and provide early identification of cognitive decline associated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Elder Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.